Additionally, Anti-Yo, Anti-Ma, and Anti-amphiphysin antibodies also presented with paraneoplastic visual impairment syndrome, subacute sensory neuronopathy, acute sensory-motor neuropathy, and Lambert-Eaton myasthenic syndrome, reflecting a diverse range of clinical manifestations. This evidence concerns the gene CDR2 and Lambert-Eaton myasthenic syndrome.